ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 137 filers reported holding ABCELLERA BIOLOGICS INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $529,253 | -28.8% | 115,055 | 0.0% | 0.20% | -29.6% |
| Q2 2023 | $743,255 | -14.3% | 115,055 | 0.0% | 0.29% | -23.9% |
| Q1 2023 | $867,515 | -25.6% | 115,055 | 0.0% | 0.38% | -31.7% |
| Q4 2022 | $1,165,507 | -80.9% | 115,055 | -81.4% | 0.55% | -77.8% |
| Q3 2022 | $6,104,000 | -9.1% | 617,213 | -2.1% | 2.49% | -6.3% |
| Q2 2022 | $6,713,000 | +49.2% | 630,326 | +36.6% | 2.66% | +71.5% |
| Q1 2022 | $4,498,000 | -31.8% | 461,289 | 0.0% | 1.55% | -20.7% |
| Q4 2021 | $6,596,000 | -28.6% | 461,289 | 0.0% | 1.96% | -29.3% |
| Q3 2021 | $9,244,000 | – | 461,289 | – | 2.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $17,358,238 | 89.37% |
| Founders Fund Growth Management, LLC | 407,017 | $1,872,278 | 5.10% |
| Prosight Management, LP | 2,446,000 | $11,251,600 | 3.57% |
| Intellectus Partners, LLC | 876,633 | $4,032,511 | 1.28% |
| Belmont Capital, LLC | 510,000 | $2,346,000 | 1.27% |
| Casdin Capital, LLC | 2,360,129 | $10,856,593 | 1.20% |
| GUARDIAN CAPITAL ADVISORS LP | 1,786,414 | $7,842,357 | 0.88% |
| Baker Brothers Advisors | 20,763,323 | $95,511,286 | 0.55% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $262,090 | 0.44% |
| Orbimed Advisors | 4,180,768 | $19,231,533 | 0.41% |